Kühnel S, Kessler M
Sandra Kühnel, Tierklinik Hofheim, Abteilung Onkologie, Im Langgewann 9, 65719 Hofheim, E-Mail:
Tierarztl Prax Ausg K Kleintiere Heimtiere. 2014;42(6):359-66. doi: 10.15654/TPK-140069. Epub 2014 Nov 24.
Retrospective analysis of dogs with gingival squamous cell carcinoma (SCC) surgically treated using jaw resection. Material and me- thods: A total of 40 dogs were enrolled in the study. Dogs with incomplete tumour resection or metastases were subjected to adjuvant chemotherapy using carboplatin. Breed, age, tumour localisation, postsurgical complications, survival times and prognostic factors were evaluated.
There were no breed predispositions. The median age was 9.5 years (mean 8.6 years; range 0.5-15.5 years). At the time of presentation, two dogs (5%) had lymph node metastases (N1). The median survival time (ST) of all the patients was 44.8 months. In 15 patients, the tumour was located in the maxilla, whereas 25 dogs had a mandibular tumour location. The median ST in dogs with maxillary tumours was 39 months (95% confidence interval [CI] 24 months), while patients with maxillary tumours survived a median of 43 months (95% CI 33-70 months). There was no significant difference in the ST in patients with maxillary versus man- dibular tumours (p = 0.985). On multivariate analysis, only the tumour stage was found to be significantly associated with survival (p = 0.0047). Patients with stage N0 survived a median of 44 months (95% CI 36-80 months). The two dogs with lymph node metastasis (N1) sur- vived 18 and 70 months following jaw resection and carboplatin chemotherapy, respectively. According to the histological findings, tumour resection was incomplete in five patients. These dogs received adjuvant carboplatin chemotherapy, resulting in an ST of between 6 and 146 months.
Prognosis depends on the tumour stage, while for complete local excision of the affected jaw segment a good prognosis can be given and the majority of the patients can be cured. The supposedly more malignant behaviour of gingival SCCs located in the caudal aspects of the oral cavity could not be confirmed. Patients with metastasis of the local lymph nodes can achieve acceptable survival times. Jaw resections have low complication rates and a good functional outcome.
回顾性分析采用颌骨切除术手术治疗的犬牙龈鳞状细胞癌(SCC)。材料与方法:本研究共纳入40只犬。肿瘤切除不完全或有转移的犬接受了卡铂辅助化疗。对品种、年龄、肿瘤定位、术后并发症、生存时间和预后因素进行了评估。
无品种易感性。中位年龄为9.5岁(平均8.6岁;范围0.5 - 15.5岁)。就诊时,2只犬(5%)有淋巴结转移(N1)。所有患者的中位生存时间(ST)为44.8个月。15例患者肿瘤位于上颌骨,25只犬肿瘤位于下颌骨。上颌骨肿瘤犬的中位生存时间为39个月(95%置信区间[CI] 24个月),而下颌骨肿瘤患者的中位生存时间为43个月(95% CI 33 - 70个月)。上颌骨肿瘤与下颌骨肿瘤患者的生存时间无显著差异(p = 0.985)。多因素分析显示,仅肿瘤分期与生存显著相关(p = 0.0047)。N0期患者的中位生存时间为44个月(95% CI 36 - 80个月)。2只发生淋巴结转移(N1)的犬在颌骨切除和卡铂化疗后分别存活了18个月和70个月。根据组织学检查结果,5例患者肿瘤切除不完全。这些犬接受了卡铂辅助化疗,生存时间在6至146个月之间。
预后取决于肿瘤分期,而对于受影响颌骨节段的完全局部切除可给出良好预后,且大多数患者可治愈。位于口腔后部的牙龈SCCs据称更具恶性行为这一点未得到证实。局部淋巴结转移患者可获得可接受的生存时间。颌骨切除术并发症发生率低,功能预后良好。